<DOC>
	<DOCNO>NCT03086382</DOCNO>
	<brief_summary>The purpose study demonstrate bioequivalence LCM tablet syrup single oral dose healthy Chinese male subject .</brief_summary>
	<brief_title>A Study Investigate Bioequivalence Lacosamide Tablet ( 200mg ) Syrup ( 10mg/ml ) Healthy Chinese Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Subject Chinese male 18 40 year age Subject clinically significant cardiovascular , renal , gastrointestinal , hepatic , metabolic , endocrine , neurological , psychiatric abnormality general good health Subject confirm study period 3 month final dose study drug , sexual intercourse woman childbearing potential , acceptable birth control method use Clinically significant range value hematology clinical chemistry variable abnormality physical examination vital sign ECG find Any clinical condition opinion investigator would make subject unsuitable study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Lacosamide</keyword>
	<keyword>Syrup</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Tablet</keyword>
</DOC>